Evidence map›Paper›PMID 24683514›Full record

ArticleBrain and behavior2014

A Neuregulin-1 schizophrenia susceptibility variant causes perihippocampal fiber tract anomalies in healthy young subjects.

Thomas Nickl-Jockschat, Tony Stöcker, Axel Krug, Valentin Markov, Ruiwang Huang, Frank Schneider, Ute Habel, Simon B Eickhoff, Klaus Zerres, Markus M Nöthen and 4 more

Open access · goldAbstract read
In one paragraph

Article in Brain and behavior, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 1 country.

Thomas Nickl-JockschatDepartment of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University Aachen, Germany ; Juelich Aachen Research Alliance - Translational Brain Medicine Juelich/Aachen, Germany.
Tony StöckerJuelich Aachen Research Alliance - Translational Brain Medicine Juelich/Aachen, Germany ; Institute of Neurosciences and Medicine-4, Juelich Research Center Juelich, Germany.
Axel KrugDepartment of Psychiatry and Psychotherapy, University of Marburg Marburg, Germany.
Valentin MarkovDepartment of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University Aachen, Germany.
Ruiwang HuangJuelich Aachen Research Alliance - Translational Brain Medicine Juelich/Aachen, Germany ; Institute of Neurosciences and Medicine-4, Juelich Research Center Juelich, Germany.
Frank SchneiderDepartment of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University Aachen, Germany ; Juelich Aachen Research Alliance - Translational Brain Medicine Juelich/Aachen, Germany.
Ute HabelDepartment of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University Aachen, Germany ; Juelich Aachen Research Alliance - Translational Brain Medicine Juelich/Aachen, Germany.
Simon B EickhoffInstitute of Clinical Neuroscience and Medical Psychology, Heinrich Heine University Düsseldorf, Germany ; Department of Neuroscience und Medicine, INM-1, Research Center Jülich Jülich, Germany.
Klaus ZerresInstitute of Human Genetics, RWTH Aachen University Aachen, Germany.
Markus M NöthenDepartment of Genomics, Life and Brain Center, University of Bonn Bonn, Germany.
Jens TreutleinDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health Mannheim, Germany.
Marcella RietschelDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health Mannheim, Germany.
Nadim Jon ShahJuelich Aachen Research Alliance - Translational Brain Medicine Juelich/Aachen, Germany ; Institute of Neurosciences and Medicine-4, Juelich Research Center Juelich, Germany ; Department of Neurology, RWTH Aachen University Aachen, Germany.
Tilo KircherDepartment of Psychiatry and Psychotherapy, University of Marburg Marburg, Germany.
RWTH Aachen University · DEJülich Aachen Research Alliance · DECentral Institute of Mental Health · DEPhilipps University of Marburg · DEForschungszentrum Jülich · DEHeinrich Heine University Düsseldorf · DEUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChanges in fiber tract architecture have gained attention as a potentially important aspect of schizophrenia neuropathology. Although the exact pathogenesis of these abnormalities yet remains to be elucidated, a genetic component is highly likely. Neuregulin-1 (NRG1) is one of the best-validated schizophrenia susceptibility genes. We here report the impact of the Neuregulin-1 rs35753505 variant on white matter structure in healthy young individuals with no family history of psychosis.

methodsWe compared fractional anisotropy in 54 subjects that were either homozygous for the risk C allele carriers (n = 31) for rs35753505 or homozygous for the T allele (n = 23) using diffusion tensor imaging with 3T. Tract-Based Spatial Statistics (TBSS), a method especially developed for diffusion data analysis, was used to improve white matter registration and to focus the statistical analysis to major fiber tracts.

resultsStatistical analysis showed that homozygous risk C allele carriers featured elevated fractional anisotropy (FA) in the right perihippocampal region and the white matter proximate to the left area 4p as well as the right hemisphere of the cerebellum. We found three clusters of reduced FA values in homozygous C allele carriers: in the left superior parietal region, the right prefrontal white matter and in the deep white matter of the left frontal lobe.

conclusionOur results highlight the importance of Neuregulin-1 for structural connectivity of the right medial temporal lobe. This finding is in line with well known neuropathological findings in this region in patients with schizophrenia.

Indexed as

AdultCerebellumFemaleGenetic Predisposition to DiseaseHippocampusHumansMagnetic Resonance ImagingMaleNeuregulin-1SchizophreniaWhite MatterYoung AdultNeuregulin-1Anatomic connectivitybrainDTIgenehippocampusMRINeuregulin-1

Identifiers

PMID24683514
PMCPMC3967537
OpenAlexW2080349092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.